E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Special Issue "Bioactive Compounds from Marine Sponges"

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: 30 July 2018

Special Issue Editor

Guest Editor
Dr. RuAngelie Edrada-Ebel

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, The John Arbuthnott Building, 161 Cathedral Street, Glasgow G4 0RE, UK
Website | E-Mail
Fax: +44 141 552 2562
Interests: natural products; drug discovery; NMR spectroscopy; metabolomics

Special Issue Information

Dear Colleagues,

In the past few decades, marine natural product research has focused a great deal on sponges. Recently, the number of scientific papers on microbial natural products derived from sponges have been increasing. Although new sources are being explored for collecting sponges for the search of novel compounds for new drugs, there is also an increasing awareness in protecting the environment. Marine natural products scientists have gone through a more ecological and sustainable way to source novel bioactive compounds from sponges. This led scientists to focus more on bioactive secondary metabolites from sponge-derived microorganisms. In the past, it has also been questioned who was the main producer of these unique natural products, considering their structural similarity with microbial metabolites.

In this Special Issue, we would like to revisit the current researches done on bioactive compounds from marine sponges. However, with the current trends in marine natural products research, we would also like to highlight bioactive compounds isolated from sponge-derived microorganisms. I would like to invite colleagues to submit articles on their current research on bioactive compounds from marine sponges, as well as secondary metabolites from sponge-derived or -associated microorganisms.

Dr. RuAngelie Edrada-Ebel
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • marine sponges
  • sponge-derived microbes
  • bioactive marine natural products

Published Papers (1 paper)

View options order results:
result details:
Displaying articles 1-1
Export citation of selected articles as:

Review

Open AccessReview Bioactive Secondary Metabolites from the Marine Sponge Genus Agelas
Mar. Drugs 2017, 15(11), 351; doi:10.3390/md15110351
Received: 19 September 2017 / Revised: 25 October 2017 / Accepted: 3 November 2017 / Published: 8 November 2017
PDF Full-text (7740 KB) | HTML Full-text | XML Full-text
Abstract
The marine sponge genus Agelas comprises a rich reservoir of species and natural products with diverse chemical structures and biological properties with potential application in new drug development. This review for the first time summarized secondary metabolites from Agelas sponges discovered in the
[...] Read more.
The marine sponge genus Agelas comprises a rich reservoir of species and natural products with diverse chemical structures and biological properties with potential application in new drug development. This review for the first time summarized secondary metabolites from Agelas sponges discovered in the past 47 years together with their bioactive effects. Full article
(This article belongs to the Special Issue Bioactive Compounds from Marine Sponges)
Figures

Figure 1

Back to Top